Tet2 inactivation enhances the anti-tumor activity of tumor-infiltrating lymphocytes

Inactivation of tumor-infiltrating lymphocytes (TIL) is one of the mechanisms mitigating anti-tumor immunity during tumor onset and progression. Epigenetic abnormalities are regarded as a major culprit contributing to the dysfunction of TILs within tumor microenvironments. In this study, we used a m...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 81; no. 8; pp. 1965 - 1976
Main Authors Lee, Minjung, Li, Jianfang, Li, Jia, Fang, Shaohai, Zhang, Joanna, Vo, Anh Tran Tram, Han, Wei, Zeng, Hongxiang, Isgandarova, Sevinj, Martinez-Moczygemba, Margarita, Zhou, Yubin, Sun, Deqiang, Huang, Yun
Format Journal Article
LanguageEnglish
Published 15.02.2021
Online AccessGet full text

Cover

Loading…
Abstract Inactivation of tumor-infiltrating lymphocytes (TIL) is one of the mechanisms mitigating anti-tumor immunity during tumor onset and progression. Epigenetic abnormalities are regarded as a major culprit contributing to the dysfunction of TILs within tumor microenvironments. In this study, we used a murine model of melanoma to discover that Tet2 inactivation significantly enhances the anti-tumor activity of TILs with an efficacy comparable to immune checkpoint inhibition imposed by anti-PD-L1 treatment. Single-cell RNA-seq analysis suggested that Tet2-deficient TILs exhibit effector-like features. Transcriptomic and ATAC-seq analysis showed that Tet2 ablation reshapes chromatin accessibility and favors binding of transcription factors geared toward CD8+ T cell activation. Furthermore, the ETS family of transcription factors contributed to augmented CD8+ T cell function following Tet2 depletion. Overall, our study establishes that Tet2 constitutes one of the epigenetic barriers that account for dysfunction of TILs, and that Tet2 inactivation could promote anti-tumor immunity to suppress tumor growth.
AbstractList Inactivation of tumor-infiltrating lymphocytes (TIL) is one of the mechanisms mitigating anti-tumor immunity during tumor onset and progression. Epigenetic abnormalities are regarded as a major culprit contributing to the dysfunction of TILs within tumor microenvironments. In this study, we used a murine model of melanoma to discover that Tet2 inactivation significantly enhances the anti-tumor activity of TILs with an efficacy comparable to immune checkpoint inhibition imposed by anti-PD-L1 treatment. Single-cell RNA-seq analysis suggested that Tet2-deficient TILs exhibit effector-like features. Transcriptomic and ATAC-seq analysis showed that Tet2 ablation reshapes chromatin accessibility and favors binding of transcription factors geared toward CD8+ T cell activation. Furthermore, the ETS family of transcription factors contributed to augmented CD8+ T cell function following Tet2 depletion. Overall, our study establishes that Tet2 constitutes one of the epigenetic barriers that account for dysfunction of TILs, and that Tet2 inactivation could promote anti-tumor immunity to suppress tumor growth.
Author Fang, Shaohai
Sun, Deqiang
Zhang, Joanna
Vo, Anh Tran Tram
Martinez-Moczygemba, Margarita
Lee, Minjung
Li, Jianfang
Han, Wei
Li, Jia
Zeng, Hongxiang
Isgandarova, Sevinj
Huang, Yun
Zhou, Yubin
AuthorAffiliation 6. Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA
7. The CPRIT scholar for cancer research
2. College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA
3. Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA
4. Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA
1. Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA
5. Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA
AuthorAffiliation_xml – name: 6. Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA
– name: 2. College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA
– name: 7. The CPRIT scholar for cancer research
– name: 3. Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA
– name: 1. Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA
– name: 4. Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA
– name: 5. Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA
Author_xml – sequence: 1
  givenname: Minjung
  surname: Lee
  fullname: Lee, Minjung
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
– sequence: 2
  givenname: Jianfang
  surname: Li
  fullname: Li, Jianfang
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
– sequence: 3
  givenname: Jia
  surname: Li
  fullname: Li, Jia
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
– sequence: 4
  givenname: Shaohai
  surname: Fang
  fullname: Fang, Shaohai
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
– sequence: 5
  givenname: Joanna
  surname: Zhang
  fullname: Zhang, Joanna
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
– sequence: 6
  givenname: Anh Tran Tram
  surname: Vo
  fullname: Vo, Anh Tran Tram
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
– sequence: 7
  givenname: Wei
  surname: Han
  fullname: Han, Wei
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
– sequence: 8
  givenname: Hongxiang
  surname: Zeng
  fullname: Zeng, Hongxiang
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
– sequence: 9
  givenname: Sevinj
  surname: Isgandarova
  fullname: Isgandarova, Sevinj
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
– sequence: 10
  givenname: Margarita
  surname: Martinez-Moczygemba
  fullname: Martinez-Moczygemba, Margarita
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
– sequence: 11
  givenname: Yubin
  surname: Zhou
  fullname: Zhou, Yubin
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
– sequence: 12
  givenname: Deqiang
  surname: Sun
  fullname: Sun, Deqiang
  email: dsun@gomicstech.com, yun.huang@tamu.edu
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
– sequence: 13
  givenname: Yun
  surname: Huang
  fullname: Huang, Yun
  email: dsun@gomicstech.com, yun.huang@tamu.edu
  organization: Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI, 48104, USA Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Center for Infectious and Inflammatory Disease, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX 77030, USA Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA The CPRIT scholar for cancer research
BookMark eNqljEFLxDAUhB-y4nZXf4KQP5A1aRoTL4IsiidPvYfYTbdP2pfSZBf67y2LCJ49DTPzzWxgRZECwL0UOym1fRBCWK4rU-72Lx-8FFyVUl1BIbWy3FSVXkHxy6xhk9LXYrUU-gbWSmn7pKUpoK5DLhmSbzKefcZILFDnqQmJ5S4wTxl5Pg1xYhcE88xiyy4JR2qxz9MyoyPr52HsYjPnkG7huvV9Cnc_uoXnt9d6_87H0-cQDk2gZdS7ccLBT7OLHt3fhrBzx3h2ViqjzaP698E3d2RjjQ
ContentType Journal Article
DBID 5PM
DOI 10.1158/0008-5472.CAN-20-3213
DatabaseName PubMed Central (Full Participant titles)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1538-7445
EndPage 1976
GroupedDBID ---
-ET
18M
29B
2WC
34G
39C
476
53G
5GY
5PM
5RE
5VS
6J9
ABOCM
ACGFO
ACIWK
ACPRK
ACSVP
ADBBV
ADCOW
ADNWM
AENEX
AETEA
AFHIN
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CS3
DIK
DU5
EBS
EJD
F5P
FRP
GX1
IH2
KQ8
L7B
LSO
OK1
P0W
P2P
PQQKQ
RCR
RHF
RHI
RNS
SJN
TR2
W2D
W8F
WH7
WOQ
YKV
YZZ
ID FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_81375763
ISSN 0008-5472
IngestDate Tue Sep 17 21:24:47 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-pubmedcentral_primary_oai_pubmedcentral_nih_gov_81375763
Notes These authors contributed equally to this study.
YH directed and oversaw the project. ML performed in vitro tissue culture work and in vivo B16-OVA immunotherapy model. ML and SF performed sequencing library preparation. ML, JZ and AV performed in vitro cytotoxic experiments. WH and HZ supported the animal model work. SI and MM supported the flow cytometry analysis. JFL, DS and JL performed sequencing data analysis. YH and YZ wrote the manuscript. All the authors participated in the discussion, data interpretation and manuscript editing discussion.
Leading contact: Name: Yun Huang, Mailing address: 2121 W. Holcombe Blvd, Houston, TX 77030 USA, Phone: 713-677-7484
Author contributions
PMID 33589517
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8137576
PublicationCentury 2000
PublicationDate 20210215
PublicationDateYYYYMMDD 2021-02-15
PublicationDate_xml – month: 2
  year: 2021
  text: 20210215
  day: 15
PublicationDecade 2020
PublicationTitle Cancer research (Chicago, Ill.)
PublicationYear 2021
SSID ssj0005105
Score 4.791113
Snippet Inactivation of tumor-infiltrating lymphocytes (TIL) is one of the mechanisms mitigating anti-tumor immunity during tumor onset and progression. Epigenetic...
SourceID pubmedcentral
SourceType Open Access Repository
StartPage 1965
Title Tet2 inactivation enhances the anti-tumor activity of tumor-infiltrating lymphocytes
URI https://pubmed.ncbi.nlm.nih.gov/PMC8137576
Volume 81
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na8IwGA7OgXgZ-2Tf5LCb1K22sfUyENkQQdnAgTeJbVw7tBVXD-6-_733bVIbp4fNS9FITejz9M3X8z4h5I6ZvGHVxwwmObxu2IzhO9doGP6Da4997sOUBZOTu716-83uDNigUPjWVEuLZFT1vrbmleyCKpQBrpgl-w9kV38KBfAZ8IUrIAzXv2EskhpaZnjZGWUVEQUI42c6noSHFhrJYoo6SU-dEoGSACwxoP5wknrmRu-VyRJAjb1lohSFuXWBJ-YVZQgUpDu-UrqRhpbJpKotJChJTzeMPhaqO8TSVC3QARKO-ZbSFX2yZeuAxwEP9bWImonyZZmNuYqvrsFseRhPVeQh1bGlaWQWc-UxLYpbrhZA0eBQ64zNhjwdZjPQM1cqI2V91VazZ2AueE1mtmrgz6Yp-pbFXBhNOnm_l-31v3Rbrmk5MPHaI_s19AvEvf3X3HSeKSVsVplKBIMm3G9tQJmUstp-S221sUv_kByoSQdtSgYdkYKIjkmpq2QVJ6SPRKI6kWhGJApEojmRaEYkGo_pJpGoRqRT8vj81G-1jbWmDWfS3mSIhuPrv0RhkBqPq8dknZFiFEfinNCR5XOT-8IS3LFd4XFh45yWufB95Jnigjg7VnK5851XpJxz85oUk_lC3MDIMRndprj-AL_ZduU
link.rule.ids 230,315,783,787,888,27937,27938
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tet2+inactivation+enhances+the+anti-tumor+activity+of+tumor-infiltrating+lymphocytes&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Lee%2C+Minjung&rft.au=Li%2C+Jianfang&rft.au=Li%2C+Jia&rft.au=Fang%2C+Shaohai&rft.date=2021-02-15&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=81&rft.issue=8&rft.spage=1965&rft.epage=1976&rft_id=info:doi/10.1158%2F0008-5472.CAN-20-3213&rft_id=info%3Apmid%2F33589517&rft.externalDBID=PMC8137576
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon